Latest News

Intravenously administered ketamine shown to reduce symptoms of chronic post-traumatic stress disorder

For the first time, evidence that a single dose of IV-administered ketamine was associated with the rapid reduction of symptoms of post-traumatic stress disorder in patients with chronic PTSD was demonstrated in a proof-of-concept, randomized, double blind crossover study. These findings could be the first step toward developing new interventions for PTSD.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Drug candidates can block pathway associated with cell death in Parkinson's disease

  • MRIs link impaired brain activity to inability to regulate emotions in autism

  • Decisions on Future Childbearing in Women Diagnosed with a Meningioma

  • Age concern in largest ever study of heroin user deaths

  • Researchers find potential anti-cancer use for anti-epilepsy drug

  • Association between parental time pressure, mental health problems among children

  • Researchers find hormone that increases the sex drive of mice

  • Smoking may increase risks for patients being treated for prostate cancer

  • Neuroscience researchers believe in quitting smoking gradually

  • Negative patient-doctor communication could worsen symptoms

  •